View in EDS

Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.

Saved in:
Bibliographic Details
Title: Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.
Authors: Wang WL; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Lee D; Division of Hematology, Stanford University School of Medicine, Stanford, CA., Cheung E; Department of Pharmacy, Stanford Health Care, Stanford, CA., Jensen A; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA., Rana MS; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Goyal A; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Hamilton M; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Ghalehsari N; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Latchford T; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Scott B; Division of Neurology & Neurological Sciences, Stanford University, Stanford, CA., Mallampet J; Cancer Correlative Science Unit, Stanford University, Stanford, CA., Heng E; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Khan H; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Zarak MS; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Lohman C; Cancer Correlative Science Unit, Stanford University, Stanford, CA., Sahaf B; Cancer Correlative Science Unit, Stanford University, Stanford, CA., Sidana S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Weng WK; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Smith M; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Bharadwaj S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Frank MJ; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Miklos DB; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Dahiya S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.
Source: Blood advances [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3313-3323.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41855506
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Lee+D%22">Lee D</searchLink>; Division of Hematology, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Cheung+E%22">Cheung E</searchLink>; Department of Pharmacy, Stanford Health Care, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Jensen+A%22">Jensen A</searchLink>; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Rana+MS%22">Rana MS</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Goyal+A%22">Goyal A</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Hamilton+M%22">Hamilton M</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Ghalehsari+N%22">Ghalehsari N</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Latchford+T%22">Latchford T</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Scott+B%22">Scott B</searchLink>; Division of Neurology & Neurological Sciences, Stanford University, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Mallampet+J%22">Mallampet J</searchLink>; Cancer Correlative Science Unit, Stanford University, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Heng+E%22">Heng E</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Khan+H%22">Khan H</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Zarak+MS%22">Zarak MS</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Lohman+C%22">Lohman C</searchLink>; Cancer Correlative Science Unit, Stanford University, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Sahaf+B%22">Sahaf B</searchLink>; Cancer Correlative Science Unit, Stanford University, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Weng+WK%22">Weng WK</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Smith+M%22">Smith M</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Bharadwaj+S%22">Bharadwaj S</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Frank+MJ%22">Frank MJ</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Miklos+DB%22">Miklos DB</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Dahiya+S%22">Dahiya S</searchLink>; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3313-3323.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41855506
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025019031
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3313
    Titles:
      – TitleFull: Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang WL
      – PersonEntity:
          Name:
            NameFull: Lee D
      – PersonEntity:
          Name:
            NameFull: Cheung E
      – PersonEntity:
          Name:
            NameFull: Jensen A
      – PersonEntity:
          Name:
            NameFull: Rana MS
      – PersonEntity:
          Name:
            NameFull: Goyal A
      – PersonEntity:
          Name:
            NameFull: Hamilton M
      – PersonEntity:
          Name:
            NameFull: Ghalehsari N
      – PersonEntity:
          Name:
            NameFull: Latchford T
      – PersonEntity:
          Name:
            NameFull: Scott B
      – PersonEntity:
          Name:
            NameFull: Mallampet J
      – PersonEntity:
          Name:
            NameFull: Heng E
      – PersonEntity:
          Name:
            NameFull: Khan H
      – PersonEntity:
          Name:
            NameFull: Zarak MS
      – PersonEntity:
          Name:
            NameFull: Lohman C
      – PersonEntity:
          Name:
            NameFull: Sahaf B
      – PersonEntity:
          Name:
            NameFull: Sidana S
      – PersonEntity:
          Name:
            NameFull: Weng WK
      – PersonEntity:
          Name:
            NameFull: Smith M
      – PersonEntity:
          Name:
            NameFull: Bharadwaj S
      – PersonEntity:
          Name:
            NameFull: Frank MJ
      – PersonEntity:
          Name:
            NameFull: Miklos DB
      – PersonEntity:
          Name:
            NameFull: Dahiya S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 05
              Text: 2026 May 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1